Allosource
- Assets
- $152.2m
- Revenue
- $172.7m
- Investments
- $3.6m
- Employees
- 619
- Location
- Centennial, CO
- Founding
- 04/1996
- Data as of
- 12/2023
- EIN
- 84-1327507
Organization Overview
Allosource is located in Centennial, CO. The organization was established in 1996. According to its NTEE Classification (E65) the organization is classified as: Organ & Tissue Banks, under the broad grouping of Health Care and related organizations. As of 12/2023, Allosource employed 619 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Allosource is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Allosource generated $172.7m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 0.8% each year. All expenses for the organization totaled $173.9m during the year ending 12/2023. While expenses have increased by 1.4% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Allosource has awarded 118 individual grants totaling $29,072,562. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
ALLOSOURCE RESPONSIBLY PROCESSES AND DISTRIBUTES HUMAN DONATED TISSUE THAT ENHANCES AND SAVES LIVES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PROCESSING AND DISTRIBUTION: WITH THE GIFT OF DONATED TISSUE, ALLOSOURCE PROVIDES INNOVATIVE CELLULAR AND TISSUE ALLOGRAFTS TO ADVANCE PATIENT HEALING. IN 2023, ALLOSOURCE FULFILLED THIS RESPONSIBILITY BY PROCESSING MORE THAN 8,300 DONORS, AND DISTRIBUTED THE TISSUE THROUGHOUT NORTH AMERICA, SOUTH AMERICA, CARIBBEAN, EUROPE, MIDDLE EAST, ASIA AND OCEANIA. MUSCULOSKELETAL AND SOFT TISSUE DONORS PROVIDE AN OPPORTUNITY TO CREATE LIFE-SAVING AND LIFE-ENHANCING SOLUTIONS IN ORTHOPEDIC, SPINE, BURN, AND WOUND PROCEDURES TO HELP RESTORE PATIENT HEALTH AND MOBILITY. ALLOSOURCE IS ACCREDITED BY THE AMERICAN ASSOCIATION OF TISSUE BANKS AND IS REGISTERED WITH THE FDA.
RESEARCH, EDUCATION, AND TRAINING: ALLOSOURCE IS DEDICATED TO ADVANCING THE USE OF TRANSPLANTABLE ALLOGENEIC CELLS AND TISSUE THROUGH PIONEERING RESEARCH. IN 2023, ALLOSOURCE CONTINUED ITS RESEARCH IN THE AREAS OF PEDIATRIC ORTHOPEDICS AND CELLULAR THERAPIES, EXPANDING THE IMPACT OF DONATION BY FINDING ADDITIONAL USES FOR TISSUE. ALLOSOURCE WORKED WITH THE 501(C)(3) ORGANIZATIONS THAT RECOVER TISSUE TO REDUCE TISSUE CONTAMINATION. WE ALSO PROVIDED EDUCATIONAL OPPORTUNITIES TO OUR PARTNER ORGAN PROCUREMENT ORGANIZATIONS TO HELP THEM INCREASE DONATION RATES IN THEIR RESPECTIVE COMMUNITIES.
CHARITABLE CONTRIBUTION ACTIVITY: IN ALIGNMENT WITH OUR MISSION, ALLOSOURCE PROVIDED GRANTS TO SUPPORT 501(C)(3) ORGANIZATIONS THAT ARE INVOLVED IN ORGAN, EYE, AND TISSUE DONATION, S.T.E.M. EDUCATION, AS WELL AS PATIENT PHYSICAL AND MENTAL HEALING. IN 2023, ALLOSOURCE GAVE GRANTS TO THREE ORGANIZATIONS TO FURTHER TISSUE DONATION AND TRANSPLANTATION AWARENESS AND PROCESSES, AND MADE CHARITABLE CONTRIBUTIONS TO ELEVEN OTHER 501(C)(3) ORGANIZATIONS THROUGH DIRECT AND MATCHING EMPLOYEE FINANCIAL DONATIONS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Name Not Listed President, CEO As Of 1/9/23 | OfficerTrustee | 40 | $509,715 |
Name Not Listed Board Member - Chair | OfficerTrustee | 3 | $0 |
Name Not Listed Board Member - Vice Chair | OfficerTrustee | 3 | $0 |
Name Not Listed Board Member - Treasurer | OfficerTrustee | 3 | $0 |
Name Not Listed President, CEO Until 1/9/23 Strategic Advisor 1/10/23-12/29/23 | OfficerTrustee | 30 | $1,423,126 |
Name Not Listed Board Member | Trustee | 3 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Eurofins Dpt Laboratory Service | 12/30/23 | $4,222,057 |
Fedex Ers Shipping Service | 12/30/23 | $2,358,057 |
North American Science Assoc Bioassay Testing | 12/30/23 | $1,920,888 |
Saunders Construction Inc Construction Project Management | 12/30/23 | $2,332,827 |
Stryker Sports Medicine Distributor Commissions | 12/30/23 | $1,301,937 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $790,852 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $790,852 |
| Total Program Service Revenue | $172,567,159 |
| Investment income | $333,089 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$1,461,766 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $172,749,079 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $346,328 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $4,533,669 |
| Compensation of current officers, directors, key employees. | $942,569 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $43,455,292 |
| Pension plan accruals and contributions | $731,696 |
| Other employee benefits | $5,133,592 |
| Payroll taxes | $3,560,717 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $728,820 |
| Fees for services: Accounting | $944,229 |
| Fees for services: Lobbying | $12,694 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $1,312,262 |
| Advertising and promotion | $310,150 |
| Office expenses | $1,406,001 |
| Information technology | $1,452,822 |
| Royalties | $1,142,909 |
| Occupancy | $1,852,958 |
| Travel | $894,483 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $331,958 |
| Interest | $872,708 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $4,053,210 |
| Insurance | $656,379 |
| All other expenses | $1,121,031 |
| Total functional expenses | $173,901,699 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $191,135 |
| Savings and temporary cash investments | $12,484,940 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $22,465,805 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $69,541,032 |
| Prepaid expenses and deferred charges | $775,264 |
| Net Land, buildings, and equipment | $35,199,134 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $3,618,652 |
| Investments—program-related | $5,246,402 |
| Intangible assets | $10,897 |
| Other assets | $2,637,920 |
| Total assets | $152,171,181 |
| Accounts payable and accrued expenses | $34,412,671 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $11,630,574 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $7,951,414 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $1,806,139 |
| Total liabilities | $55,800,798 |
| Net assets without donor restrictions | $96,370,383 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $152,171,181 |
Grants Awarded
Over the last fiscal year, Allosource has awarded $338,352 in support to 8 organizations.
| Grant Recipient | Amount |
|---|---|
LIMB PRESERVATION FOUNDATION PURPOSE: TO SUPPORT MISSION | $30,000 |
DONATE LIFE NEW YORK STATE PURPOSE: TO SUPPORT MISSION | $35,000 |
ARRUPE COPORATE WORK STUDY PROGRAM PURPOSE: TO SUPPORT MISSION | $8,200 |
THE PHOENIX SOCIETY PURPOSE: TO SUPPORT MISSION | $175,000 |
DONOR ALLIANCE INC PURPOSE: TO SUPPORT MISSION | $5,555 |
CHICAGO SPORTS SUMMIT FOUNDATION PURPOSE: TO SUPPORT MISSION | $5,000 |